Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-03
2011-05-03
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S320000, C514S456000
Reexamination Certificate
active
07935714
ABSTRACT:
Provided herein is a composition that contains an effective amount of one or more compounds for treating, preventing, or ameliorating a disorder such as insomnia or another sleeping disorder and using the composition.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5502047 (1996-03-01), Kavey
patent: 5643897 (1997-07-01), Kavey
patent: 5650433 (1997-07-01), Watanabe et al.
patent: 6211229 (2001-04-01), Kavey
patent: 6224872 (2001-05-01), Shibuya et al.
patent: 6344487 (2002-02-01), Kavey
patent: 2003/0206895 (2003-11-01), Cavazza
patent: 2005/0272812 (2005-12-01), Pettegrew et al.
patent: WO 01/26666 (2001-04-01), None
patent: WO 02/15901 (2002-02-01), None
Jungluth et al. Fresenius J. Anal. Chem. 2000. vol. 367, pp. 661-666.
International Search Report for PCT/US2005/016783, mailed Dec. 18, 2006, 19 pgs.
Bioadhesion—Possibilities and Future Trends; ed. by Gurny and Junginger. Stuttgart: Wiss. Verl.-Ges. (1990).
Carlson,Design and Optimization in Organic Synthesis, Elsevier Science Publishers, B.V. (1992).
Matsuda,Structural Requirements of Flavonoids and Related Compounds for Aldose Reductase Inhibitory Activity, Chemical & Pharmaceutical Bulletin, vol. 50, No. 6, pp. 788-795 (2002).
Cozanni et al.,Efficient Photosensitization of Malignant Human Cells in Vitro by Liposome-Bound Porphyrins, Chem.-Biol. Interactions, vol. 53, pp. 131-143 (1985).
Jori et al.,Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats, Br. J. Cancer, vol. 48, pp. 307-309 (1983).
Jori et al.,Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice, Br. J. Cancer, vol. 53, No. 5, pp. 615-621 (1986).
Hosny et al.,Hydroxylations and Methylations of Quercetin, Fisetin, and Catechin by Streptomyces griseus, Journal of Natural Products, vol. 64, No. 4, pp. 462-465 (2001).
Ikramov et al.,Flavonoids of Lagonychium Farctum, Chemistry of Natural Compounds, vol. 26, No. 2, pp. 226-227 (1990), translated from Khimiya Prirodnykh Soedinenii, No. 2, pp. 274-276 (1990).
Jungbluth et al.,Oxidation of flavonols with Cu(II)and Fe(II)and Fe(III)in aqueous media, J. Chem. Soc. Perkin Trans. vol. 2, pp. 1946-1952 (2000).
Sicuro et al.,Dark- and Light-Interaction of Porphyrins with Malignant Cell Compartment, Med. Biol. Environ., vol. 15 pp. 67-70 (1987).
Smit et al.,Organic Synthesis, The Science Behind the Art, The Royal Society of Chemistry (1998).
Zhiwu Xuebao,Studies on the Chemical Constituents of Limonium Aureum(L.)Hill, (English abstract) vol. 31, No. 3, pp. 205-208 (1989).
Bell et al., “Skeletal Advancement for the treatment of obstructive sleep apnea in children”, Cleft Palate-Carniofacial Journal, vol. 38, No. 2, pp. 147-154 (2001).
Ford et al., “Epidemiologic study of sleep disturbance and psychiatric disorders”, JAMA 262, pp. 1479-1484 (1989).
Kupfer et al., “Management of Insomnia”, The New England J. of Med. vol. 336, No. 5, pp. 341-346 (1997).
Simon et al., “Prevalence, burden and treatment of insomnia in primary care”, Am. J. Psychiatry 154, pp. 1417-1423 (1997).
Stafford et al., “Comparison of Proanthocyanidins and related compounds in leaves and leaf-derived cell cultures of Ginkgo bioloba L. Pseudotsuga menziesii Franco, and Ribes sanguineum Pursh”, Plant Physiol. vol. 82, pp. 1132-1138 (1996).
Chan Hsiao Chang
Chung Yiu Wa
Gou Yu Lin
Rowlands Dewi Kenneth
Bright Future Pharmaceutical Laboratories
Jean-Louis Samira
Padmanabhan Sreeni
Squire Sanders & Dempsey (US) LLP
LandOfFree
Compositions for sleeping disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for sleeping disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for sleeping disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2681279